These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3767540

  • 1. Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis.
    Felsenfeld AJ, Drezner MK, Llach F.
    Arch Intern Med; 1986 Oct; 146(10):1941-5. PubMed ID: 3767540
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
    Gkonos PJ, London R, Hendler ED.
    N Engl J Med; 1984 Dec 27; 311(26):1683-5. PubMed ID: 6548798
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB.
    Am J Kidney Dis; 2007 Jun 27; 49(6):814-23. PubMed ID: 17533024
    [Abstract] [Full Text] [Related]

  • 6. Hypercalcemia, inappropriate calcitriol levels, and tuberculosis on hemodialysis.
    Peces R, Pobes A, Díaz-Corte C, Gago E.
    Scand J Urol Nephrol; 2000 Aug 27; 34(4):287-8. PubMed ID: 11095092
    [Abstract] [Full Text] [Related]

  • 7. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
    Felsenfeld AJ, Ross D, Rodriguez M.
    J Am Soc Nephrol; 1991 Dec 27; 2(6):1136-43. PubMed ID: 1777594
    [Abstract] [Full Text] [Related]

  • 8. Effect of sevelamer on mineral and lipid abnormalities in hemodialysis patients.
    Hamida FB, Fatma LB, Barbouch S, Kaaroud H, Helal I, Hedri H, Abdallah TB, Maiz HB, Kheder A.
    Saudi J Kidney Dis Transpl; 2008 Mar 27; 19(2):183-8. PubMed ID: 18310864
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E, Bernardini J, Holley J, Chen T, Piraino B.
    Adv Perit Dial; 1993 Mar 27; 9():280-3. PubMed ID: 8105943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J, Martin KJ, González EA, Acchiardo SR, Valdin JR, Soltanek C.
    Clin Nephrol; 2001 Oct 27; 56(4):315-23. PubMed ID: 11680662
    [Abstract] [Full Text] [Related]

  • 13. A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients.
    Peng SJ, Yang CS, Ferng SH, Chen LY.
    Miner Electrolyte Metab; 1997 Oct 27; 23(1):13-8. PubMed ID: 9058364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients.
    Hardy P, Morinière PH, Tribout B, Hamdini N, Marié A, Bouffandeau B, Pruna A, Fournier A.
    J Nephrol; 1999 Oct 27; 12(6):398-403. PubMed ID: 10626831
    [Abstract] [Full Text] [Related]

  • 16. [Recurrence of sarcoidosis in a hemodialysis patient confirmed by abnormal calcium metabolism].
    Tanaka K, Tanimoto H, Sakai K, Arai K, Mizuiri S, Hasegawa A, Otsuka T, Uchino M.
    Clin Calcium; 2005 Sep 27; 15 Suppl 1():83-5; discussion 86. PubMed ID: 16272637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
    Malberti F, Surian M, Cosci P.
    Kidney Int Suppl; 1993 Jun 27; 41():S125-30. PubMed ID: 8320905
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.